SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Inogen and Rotech Ink Long-Term Supply Deal

Inogen has entered into a long-term supply agreement with Rotech Healthcare, coinciding with its divestiture of its rental business. This deal aims to broaden patient access to Inogen's oxygen concentrators via Rotech's nationwide distribution.

INGN

Story updates

09:26:50 PM UTC
SquawkNews
Inogen's board has approved a $15 million increase to the company's share repurchase authorization, contingent on closing the Rotech deal. The expansion brings total buyback capacity to $45 million, with an expiration set for June 30, 2028. The company isn't obligated to repurchase any specific num…